Endovascular treatment of unruptured intracranial aneurysms and circulating endothelial cells

Jean-François Vendrell1, Renaud Cezar, Nils Kuster

  • 1Department of Neuroradiology, University Hospital Center, Guy de Chauliac Hospital, 80 Avenue Augustin Fliche, 34295 Montpellier Cedex, France. jfvendrell@yahoo.fr

Insights

Endovascular treatment (EVT) of brain aneurysms releases circulating endothelial cells (CECs), potentially causing silent ischemic brain lesions. Monitoring CECs may help optimize EVT and reduce complications.

Area of Science:

  • Neuroendovascular research
  • Vascular biology
  • Medical device technology

Background:

  • Endovascular treatment (EVT) is a common procedure for unruptured intracranial aneurysms.
  • Complications, such as silent ischemic brain lesions, can occur despite successful treatment.
  • Circulating endothelial cells (CECs) are shed from damaged blood vessel walls.

Purpose of the Study:

  • To investigate the role of CECs in complications following EVT for intracranial aneurysms.
  • To characterize and quantify CECs in different blood compartments before and after EVT.
  • To correlate CEC levels with the occurrence of ischemic brain events.

Main Methods:

  • CECs were identified and counted using the CellTracks(®) System in blood samples from the femoral artery, internal carotid artery (before and after EVT), and peripheral veins (before and after EVT).
  • Patients (n=15) underwent diffusion-weighted imaging (DWI-MRI) to assess ischemic brain lesions before and 24 hours after EVT.
  • CEC characterization involved markers CD146, CD105, CD45, and DAPI.

Main Results:

  • Higher numbers of single CECs and clusters were found in the internal carotid artery (ICA) before EVT compared to other sampling sites.
  • Large CEC clusters were predominantly observed in the ICA, suggesting device-induced endothelial injury.
  • Silent ischemic brain lesions were detected in 60% (9/15) of patients, despite uneventful clinical recovery.

Conclusions:

  • EVT procedures can lead to the detachment of CECs from arterial walls, potentially contributing to the formation of silent ischemic brain lesions.
  • Quantifying CECs alongside DWI-MRI may offer a valuable method for monitoring EVT outcomes and refining endovascular device strategies.
  • This approach could help minimize EVT-related complications.
Abstract